ClinicalTrials.govpublic full text
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
relapsed/refractory multiple myeloma, plasma cell leukemia (pcl), plasma cell leukemia, il-15-armored car-t, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 890940
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.